Hiring for a Senior CRA, SCRA, or Clinical Research Manager and wondering why your advert isn't generating the calibre of response you need? The problem probably isn't the role. It's the channel.
The strongest clinical development professionals aren't refreshing job boards. They're in the middle of a study, managing a site, or heads-down on a regulatory submission. They may be open to a move, but they're not looking for one. That distinction matters enormously, and most hiring processes are built entirely around the second group.
Industry data consistently shows that over half of employed biopharma professionals are open to new opportunities but not actively seeking them. That's the pool your advert never reaches.
Passive candidates in clinical development aren't passive because they're disengaged or satisfied with the status quo. They're passive because nothing has given them a reason to act. A job advert, by design, asks the candidate to do the work: to find it, evaluate it, write a CV, and approach a stranger. For someone not in job-seeking mode, that's a significant ask in exchange for an unknown quantity.
What these candidates are actually waiting for is a reason to pay attention. That reason isn't a list of responsibilities or a salary band. It's a conversation that starts with something relevant to where they are in their career, not where a hiring manager needs them to be.
The other factor is self-selection. Experienced clinical development professionals are often selective in ways that generic adverts can't accommodate. A Senior CRA who's spent three years on early-phase oncology trials is filtering for science, not just seniority. An SCRA weighing up their options wants to know about the team structure, the mandate they'd have, and whether the programme is likely to run long enough to be worth joining. An advert that says "exciting opportunity within a growing CRO" answers none of those questions.
When a passive clinical development candidate does decide to move, the decision is rarely about money alone, though compensation matters. What tends to tip the balance is a combination of four things: the science or therapeutic area, the stage of the programme, the quality of the team they'd be joining, and the mandate they'd actually have in the role.
For candidates in biotech specifically, stage is often the primary filter. Early-phase programmes attract people who want to be close to the science and don't mind the ambiguity. Later-phase and commercial-stage roles appeal to those who want to see something through to market. Neither group is more ambitious than the other; they just have different ideas about what a good career move looks like.
CRO environments introduce another layer of complexity. The best CRO clinical professionals are weighing up study breadth, sponsor relationships, and whether the organisation gives them genuine development opportunities or just headcount. Understanding which of those factors matters most to a specific candidate is the difference between a compelling approach and a generic one.
None of this can be conveyed in a job advert. It can only be conveyed in a conversation, and that conversation has to happen before the candidate is in active search mode, not after.
The organisations that hire consistently well in clinical development tend to have one thing in common: they don't start recruiting when the role opens. They already know who they want to talk to.
That means maintaining relationships with strong candidates over months or years, staying visible in the markets you're likely to hire from, and understanding what's happening in a candidate's career well before they've decided to move. It's a fundamentally different operating model from posting a job and filtering applications.
In practice, this looks like proactive sourcing that maps the candidate landscape for a particular specialism, combined with an outreach approach built around the candidate's situation rather than the vacancy. A Senior CRA who's been on the same Phase II study for eighteen months is worth a very different conversation than one who's just moved roles. Timing and context matter.
The pitch problem compounds all of this. Clinical development professionals at the senior end of the market have seen every variation of "exciting opportunity" and "competitive package." Language like this doesn't signal anything. It's noise. A compelling approach to a passive candidate names the specific things that are genuinely differentiated about the role, acknowledges that they're probably not looking, and makes it easy to say yes to a conversation rather than a commitment.
When the process is built around the candidate's decision rather than the hiring manager's timeline, outcomes change significantly. Across search processes run this way, offer acceptance rates of 98% are achievable, not because candidates are being pressured into decisions, but because the groundwork has been done properly. The candidate has enough information to make a confident choice, and the employer has enough insight into the candidate to know the fit is real before an offer is made.
Working with a high-growth biotech on a series of clinical operations hires recently, the difference between an advert-led approach and a proactive search was stark. The advert attracted volume, but the strongest candidates in the target market had never seen it. Mapping that market properly, then approaching relevant professionals with a specific, informed pitch, surfaced candidates who were open but not looking, and who had no reason to apply to anything.
The clinical development talent market isn't about to get easier. As more sponsors insist on experienced study managers and CRAs with specific therapeutic area backgrounds, the competition for that profile intensifies. Organisations that rely on reactive advertising are fishing in an increasingly shallow pool.
The candidates worth hiring are out there. They're just not on the job boards, and the process that reaches them looks nothing like the one most organisations are running.